Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo
Erianin may exerted its anti-tumor effect in DDP-resistant LUAD cells by regulating the Wnt3/β-Catenin/Survivin/Bcl-2/Caspase-3/Cyclin D1 axis.
Authors
- Yiling Ruan
- Beibei Wang (ORCID: https://orcid.org/0000-0003-2362-2905)
- Tong Wang (ORCID: https://orcid.org/0000-0002-1828-5935)
- Mingjun Zhang (ORCID: https://orcid.org/0000-0002-3595-7043)
- Lingxue Tang (ORCID: https://orcid.org/0000-0002-2234-9786)
- Jie Xue
Institutions
- Anhui Medical University (CN)
- Huaibei Mining (China) (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1186/s41065-024-00351-x
- Citations
- 6
- Primary Topic
- Biological and pharmacological studies of plants
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- Anhui Medical University